Red/Near-Infrared Light Therapy

Red and near-infrared light therapy, also known as photobiomodulation or low-level laser therapy, involves exposure to specific wavelengths of light (typically 660-850nm) to potentially support cellular function and tissue repair. Research indicates these wavelengths may penetrate skin and interact with cellular components, particularly mitochondrial enzymes, potentially enhancing ATP production and cellular metabolism. Studies suggest the therapy may support wound healing, reduce inflammation, and improve muscle recovery through various photobiological mechanisms.

Human trials have investigated applications ranging from wound healing and pain management to muscle recovery and skin health. Research suggests potential benefits for conditions including chronic wounds, muscle soreness, joint pain, and skin aging, though results vary across studies and applications. The therapy appears to work through multiple pathways including enhanced mitochondrial function, improved blood flow, and modulation of inflammatory responses. Treatment protocols typically involve daily sessions of 10-20 minutes using LED panels or targeted devices.

The intervention is generally well-tolerated with minimal reported side effects, though proper eye protection is recommended during treatment. Home devices have become increasingly accessible, ranging from small targeted units to full-body LED panels. While research continues to explore optimal protocols and applications, the therapy's non-invasive nature and low risk profile have contributed to growing interest in both clinical and consumer settings.